Skip to content

Clinical trials

Phase 1 Leukemia, Myeloid, Acute trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1 Country / region: Netherlands Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20121
20141
20153
20161
20174
20203
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated6
Active, not recruiting5
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AbbVie2
AstraZeneca2
AvenCell Europe GmbH2
Amgen1
Biomea Fusion Inc.1
Byondis B.V.1
Epizyme, Inc.1
GlaxoSmithKline1
Institut de Recherches Internationales Servier1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute20
Myelodysplastic Syndromes7
Precursor Cell Lymphoblastic Leukemia-Lymphoma5
Recurrence5
Multiple Myeloma4
Neoplasms4
Hematologic Neoplasms3
Leukemia3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Non-Hodgkin3

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.